(Q36700158)

15 August 2017

1 reference

title

The pharmacological management of childhood anxiety disorders: a review (English)

1 reference

15 August 2017

Shauna P Reinblatt

1

1 reference

PubMed ID

17205317

15 August 2017

Mark A Riddle

series ordinal

2

1 reference

15 August 2017

5 January 2007

1 reference

15 August 2017

20

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

15 August 2017

191

1 reference

15 August 2017

67-86

1 reference

15 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-006-0644-4

15 August 2017

0 references

cites work

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0644-4

Fluoxetine for the treatment of childhood anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0644-4

Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0644-4

Psychopathology from adolescence into young adulthood: an 8-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0644-4

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0644-4

Using numerical results from systematic reviews in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0644-4

A controlled clinical trial of alprazolam for the treatment of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0644-4

Long-term Therapeutic Use of Benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0644-4

Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0644-4

Depressive comorbidity in children and adolescents: empirical, theoretical, and methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0644-4

Alcohol dependence and anxiety disorders: what is the relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0644-4

Stability and natural history of DSM-III childhood diagnoses

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties

1 reference

12 December 2020

Chronic fluoxetine administration to juvenile rats prevents age-associated dendritic spine proliferation in hippocampus

1 reference

12 December 2020

Children with prepubertal-onset major depressive disorder and anxiety grown up.

1 reference

12 December 2020

A therapeutic approach to children and adolescents with anxiety disorders and associated comorbid conditions

1 reference

12 December 2020

Selective serotonin reuptake inhibitor-induced apathy: a pediatric case series.

1 reference

12 December 2020

Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder

1 reference

12 December 2020

Traumas and posttraumatic stress disorder in a community population of older adolescents.

1 reference

12 December 2020

Psychopharmacology interventions for pediatric anxiety disorders: a research update

1 reference

12 December 2020

A family study of obsessive-compulsive disorder

1 reference

12 December 2020

School phobia: a therapeutic trial with clomipramine and short-term outcome

1 reference

12 December 2020

Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder

1 reference

12 December 2020

Resolution of fear of flying with fluoxetine treatment

1 reference

12 December 2020

Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors

1 reference

12 December 2020

Should selective serotonin reuptake inhibitors be prescribed for children with major depressive and anxiety disorders?

1 reference

12 December 2020

Psychopharmacologic treatment of pediatric anxiety disorders

1 reference

12 December 2020

Use of selective serotonin reuptake inhibitors for the treatment of childhood panic disorder: a pilot study

1 reference

12 December 2020

Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study

1 reference

12 December 2020

Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: a pilot study

1 reference

12 December 2020

Anxiolytics, adrenergic agents, and naltrexone

1 reference

12 December 2020

Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial

1 reference

12 December 2020

Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study

1 reference

12 December 2020

1 reference

12 December 2020

Imipramine treatment of children with separation anxiety disorder

1 reference

12 December 2020

Clonidine for posttraumatic stress disorder in preschool children

1 reference

12 December 2020

Does panic disorder exist in childhood?

1 reference

12 December 2020

Treatment of cancer phobia with fluoxetine

1 reference

12 December 2020

Panic disorder in clinically referred children and adolescents

1 reference

12 December 2020

Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study

1 reference

12 December 2020

Depression, antidepressants and suicidality: a critical appraisal

1 reference

12 December 2020

Double-blind placebo-controlled pilot study of paroxetine for specific phobia.

1 reference

12 December 2020

Posttraumatic stress disorder in peers of adolescent suicide victims: predisposing factors and phenomenology

1 reference

12 December 2020

Complications of SSRI treatment

1 reference

12 December 2020

Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials

1 reference

12 December 2020

Carbamazepine for PTSD

1 reference

12 December 2020

Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear

1 reference

12 December 2020

Obsessive compulsive disorder in adolescence: an epidemiological study

1 reference

12 December 2020

Comparative studies of pharmacotherapy for school refusal

1 reference

12 December 2020

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder

1 reference

12 December 2020

Treatment of ADHD with fluoxetine: a preliminary trial.

1 reference

12 December 2020

Pharmacologic treatment of generalized anxiety disorder

1 reference

12 December 2020

Maternal and environmental influences on the adrenocortical response to stress in weanling rats

1 reference

12 December 2020

NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses

1 reference

12 December 2020

Ssri-induced sexual dysfunction in adolescents

1 reference

12 December 2020

From the Food and Drug Administration

1 reference

12 December 2020

Fluoxetine treatment of children with selective mutism: an open trial.

1 reference

12 December 2020

Hormonal Influences on Brain Organization in Infant Rats

1 reference

12 December 2020

Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation

1 reference

12 December 2020

The expert consensus guideline series. Treatment of Posttraumatic Stress Disorder. The Expert Consensus Panels for PTSD

1 reference

12 December 2020

Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder

1 reference

12 December 2020

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups

1 reference

12 December 2020

Six-year predictors of problems in a national sample of children and youth: I. Cross-informant syndromes.

1 reference

12 December 2020

Anxiety attacks with subsequent agoraphobia

1 reference

12 December 2020

Sertraline in children and adolescents with social anxiety disorder: an open trial

1 reference

12 December 2020

Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents

1 reference

12 December 2020

Disinhibition and anger outbursts in adolescents treated with clonazepam.

1 reference

12 December 2020

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

1 reference

12 December 2020

Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study

1 reference

12 December 2020

Efficacy of sertraline in a 12-week trial for generalized anxiety disorder

1 reference

12 December 2020

The pharmacotherapy of anxiety disorders in children and adolescents

1 reference

12 December 2020

Elective mutism as a variant of social phobia

1 reference

12 December 2020

Emotional blunting, sexual dysfunction and SSRIs

1 reference

12 December 2020

The prospective relation between dimensions of anxiety and the initiation of adolescent alcohol use.

1 reference

12 December 2020

Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder

1 reference

12 December 2020

Open fluoxetine treatment of mixed anxiety disorders in children and adolescents

1 reference

12 December 2020

Pharmacologic treatment of anxiety disorders in children and adolescents.

1 reference

12 December 2020

Case study: fluoxetine in the multimodal treatment of a preschool child with selective mutism

1 reference

12 December 2020

Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. American Academy of Child and Adolescent Psychiatry

1 reference

12 December 2020

The relationship between antidepressant medication use and rate of suicide

1 reference

12 December 2020

Comorbidity in childhood anxiety disorders and treatment outcome

1 reference

12 December 2020

A prospective study of childhood anxiety disorders.

1 reference

12 December 2020

Selective serotonin reuptake inhibitor-induced sexual dysfunction in adolescents: a review

1 reference

12 December 2020

Fluoxetine in children and adolescents with OCD: a placebo-controlled trial

1 reference

12 December 2020

Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders

1 reference

12 December 2020

Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder

1 reference

12 December 2020

Imipramine plus cognitive-behavioral therapy in the treatment of school refusal

1 reference

12 December 2020

Suicide risk during antidepressant treatment.

1 reference

12 December 2020

Treating children and adolescents with selective serotonin reuptake inhibitors: how long is appropriate?

1 reference

12 December 2020

Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?

1 reference

12 December 2020

Paroxetine, other antidepressants, and youth suicide in New York City: 1993 through 1998.

1 reference

12 December 2020

Sertraline treatment of 5 children diagnosed with selective mutism: a single-case research trial

1 reference

12 December 2020

Clonazepam in childhood anxiety disorders

1 reference

12 December 2020

A community study of anxiety in children and adolescents

1 reference

12 December 2020

Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders

1 reference

12 December 2020

Treatment of school refusal: one-year follow-up.

1 reference

12 December 2020

Depression in anxious children: possible factors in comorbidity

1 reference

12 December 2020

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

12 December 2020

Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial

1 reference

12 December 2020

Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents

1 reference

12 December 2020

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial

1 reference

12 December 2020

Lifetime comorbidity among anxiety disorders and between anxiety disorders and other mental disorders in adolescents.

1 reference

12 December 2020

Comorbidity and severity of anxiety and depressive disorders in a clinic sample

1 reference

12 December 2020

Treating anxiety disorders in children: results of a randomized clinical trial

1 reference

12 December 2020

Fluoxetine for the treatment of social phobia

1 reference

12 December 2020

Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA).

1 reference

12 December 2020

Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents

1 reference

12 December 2020

Pharmacokinetics of benzodiazepines and psychostimulants in children

1 reference

12 December 2020

Diagnosis of panic disorder in prepubertal children.

1 reference

12 December 2020

Child-adult anxiety disorders

1 reference

12 December 2020

A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder

1 reference

12 December 2020

Therapy for youths with anxiety disorders: a second randomized clinical trial

1 reference

12 December 2020

Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.

1 reference

12 December 2020

The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder

1 reference

12 December 2020

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial

1 reference

12 December 2020

Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study

1 reference

12 December 2020

Pharmacologic treatment of obsessive compulsive disorders

1 reference

12 December 2020

The treatment of anxiety disorders in children and adolescents

1 reference

12 December 2020

Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life.

1 reference

12 December 2020

Panic disorder and agoraphobia in consecutively referred children and adolescents

1 reference

12 December 2020

10.1007/S00213-006-0644-4

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17205317